| Literature DB >> 29278371 |
Erick P Gutiérrez-Grijalva1, Manuel A Picos-Salas2, Nayely Leyva-López3, Marilyn S Criollo-Mendoza4, Gabriela Vazquez-Olivo5, J Basilio Heredia6.
Abstract
Several herb species classified as oregano have been widely used in folk medicine to alleviate inflammation-related diseases, respiratory and digestive disorders, headaches, rheumatism, diabetes and others. These potential health benefits are partially attributed to the phytochemical compounds in oregano such as flavonoids (FL) and phenolic acids (PA). Flavonoids and phenolic acids are among the most abundant and most studied phytochemicals in oregano species. Epidemiological, in vitro and in vivo experiments have related long-term consumption of dietary FL and PA with a decreased risk of incidence of chronic diseases. The aim of this manuscript is to summarize the latest studies on the identification and distribution of flavonoids and phenolic compounds from oregano species and their potential antioxidant, anti-inflammatory and anti-cancer health benefits.Entities:
Keywords: antioxidant; flavones; flavonoids; flavonols; hydroxybenzoic acids; hydroxycinnamic acids; oregano; phenolic acids; phytochemicals
Year: 2017 PMID: 29278371 PMCID: PMC5874591 DOI: 10.3390/plants7010002
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1General structure of hydroxycinnamic acids, hydroxybenzoic acids and flavonoids.
Figure 2Chemical structure of common flavones commonly found in oregano species. (a) apigenin, (b) luteolin, (c) scutellarein, (d) apigenin-7-O-glucoside, (e) luteolin-7-O-glucoside, (f) luteolin-7-O-glucuronide. Structures from Phenol-Explorer Database, Version 3.6 [20].
Principal components of flavonoids and phenolic compounds of different oregano species.
| Oregano Species | Origin | Extraction Solvent | Flavonoids and Phenolic Acids Constituents | Reference |
|---|---|---|---|---|
| Mexico | Methanol/acetone/water (50:40:10) | 3- | [ | |
| Brazil | Methanol 62.5% | Apigenin-7- | [ | |
| France | Methanol/hydromethanol | Luteolin-7-diglucuronide, verbascoside, chlorogenic acid | [ | |
| Brazil | Chloroform | 5,5′′-dihydroxy-6,4′,6′′,3′′′,4′′′-pentamethoxy-[C7–O–C7′′]-biflavone, 4′,4,5,5′′-tetrahydroxy-6,6′′,3′′′-trimethoxy-[C7–O–C7′′]-biflavone | [ | |
| Germany | Water | Verbasoside, luteolin-7-diglucuronide, apigenin-7-diglucuronide | [ | |
| Mexico | Methanol/acetone/water (50:40:10) | Quercetin
| [ | |
| NR 1 | Methanol 70% | 6-Hydroxyluteolin 7- | [ | |
| USA | Methanol 100% | Eriodictyol, naringenin, hispidulin, cirsimaritin | [ | |
| Colombia | Methanol/hydromethanol | Naringenin, apigenin | [ | |
| Colombia | Methanol 62.5% | Quercetin, naringenina, luteolin, pinocembrin | [ | |
| Mexico | Methanol/acetone/water (50:40:10) | Quercetin- | [ | |
| Poland | Water | Caffeic acid, lithospermic acid, rosmarinic acid | [ | |
| Turkey | Water | Gallic acid, caffeic acid, 4-hydroxybenzaldehyde,
| [ | |
| Greece | Methanol 62.5%/BHT | Vanillic acid, protocatechuic acid, syringic acid, gallic acid, cinnamic acid,
| [ | |
| Greece | Water | Chlorogenic acid, rutin, luteolin-7- | [ | |
| Greece | Methanol | Caffeic acid, rosmarinic acid | [ | |
| Germany | Methanol 60%/Formic acid 1% | Apigenin-6,8-di-C-glucoside, luteolin-7′- | [ | |
| Tunisia | Methanol | Dihydroxybenzoic acid hexose, syringic acid, vanillic acid, dihydroxybenzoic acid,
| [ | |
| Greece | Water | Vanillic acid, protocatechuic acid, syringic acid, gallic acid, cinnamic acid,
| [ | |
| Poland | Methanol | Protocatechuic acid,
| [ | |
| Turkey | Methanol 80% | Caffeic acid glucoside, epigallocatechin, arbutin, luteolin ruitinoside, luteolin glucuronide, rosmarinic acid, dihydroquercetin, dihydroluteolin, apigenin, quercetin, quercetin arabinoside, luteolin-7- | [ | |
| Germany | Methanol 50% | Luteolin-6,8-di-C-glucoside, apigenin-6,8-di-C-glucoside, luteolin-glucuronide, rosmarinic acid, apigenin-glucuronide, lithospermic acid, apigenin | [ | |
| USA | Methanol 80% | Eriodictyol 6,8-di-C-glucoside, eriodictyol 7- | [ | |
| Turkey | Water | Gallic acid, caffeic acid,
| [ | |
| Italy | Cascade extraction with ethyl acetate and ethanol | Eriodictyol 7- | [ | |
| Greece | Cascade extraction with hexane and ethyl acetate | Salvianolic acid H, salvianolic acid B, rosmarinic acid, salvianolic acid C, eriodictyol, naringenin | [ | |
| Finland | Methanol 40% | Calleryanin 3,4-dihydroxybenzoate, gastrodin 3,4-dihydroxybenzoate, calleryanin 3-hydroxy,4-methoxybenzoate | [ | |
| Portugal | Methanol 80% | Gallic acid, 3,4-dihydroxybenzoic acid, (+)-catechin, caffeic acid, (−)-epicatechin, rosmarinic acid | [ | |
| Oregano 2 | Turkey | Methanol 80% | Gallic acid, syringic acid, vanillic acid, protocatechuic acid, chlorogenic acid, | [ |
| NR 1 | Phosphate buffer | Vanillic acid, caffeic acid, luteolin, rosmarinic acid, hispidulin | [ |
1 Not reported, 2 Species not mentioned.
A summary of the antioxidant capacity of flavonoids and phenolic acids of different oregano species.
| Oregano Species | Extract | Compounds | Plant Part | Antioxidant Assay | Reference |
|---|---|---|---|---|---|
| Methanol | Rosmarinic, caffeic,
| Stem | DPPH, superoxide, TAC | [ | |
| Aqueous, methanol | Gallic, protocatechuic, syringic,
| Leaves | TPC, DPPH | [ | |
| Aqueous | Apigenin-7- | Leaves | TPC, DPPH | [ | |
| Methanol | Rosmarinic acid, naringenin | Aerial parts | TPC, DPPH | [ | |
| Methanol | Eriodictyol, naringenin, hispidulin, cirsimaritin | Leaves, commercial herbs | TPC, ORAC | [ | |
| Sequentially with hexane, acetone and methanol; Aqueous | Methanolic: gallic, caffeic, ferulic and rosmarinic acids. Aqueous: gallic, caffeic, protocatechuic and rosmarinic acids | Leaves | TPC, DPPH, FRAP | [ | |
| Aqueous | Rosmarinic, caffeic and vanillic acids, epicatechin, catechin, genistein | Leaves and flowers | TPC, DPPH, FRAP | [ | |
| Methanol, previously deffated with n-hexane | Caffeic acid, luteolin glucoside | Not specified | DPPH, FRAP | [ | |
| Methanol microwave-assisted | Rosmarinic and caffeic acid, apigenin, rutin | Aerial parts | TPC, DPPH, CUPRAC | [ | |
| Aqueous, methanol | Rosmarinic and caffeic acids | Leaves | TPC, DPPH, β-carotene bleaching | [ | |
| Methanol | Rosmarinic acid, eriodictyol, naringenin, hispidulin, cirsimaritin | Leaves, commercial herbs | TPC, ORAC | [ | |
| Methanol | Rosmarinic acid, epigallocatechin, quercetin, apigenin | Not specified | DPPH, FRAP | [ | |
| Ethanol | Chlorogenic, ferulic,
| Not specified | TPC, DPPH, ABTS | [ | |
| Aqueous | Leaves and flowers | TPC, FRAP | [ | ||
| Methanol | Rosmarinic acid | Leaves | TPC, ORAC | [ | |
| Methanol | Rosmarinic acid and (−)-epicatechin | Leaves | DPPH; ABTS, FRAP | [ | |
| Water, methanol, ethyl acetate, hexane | Rosmarinic, caffeic, chicoric and
| Leaves | TPC, DPPH, TAC, RP, superoxide | [ | |
| Methanol | Rosmarinic acid, eriodictyol, naringenin | Leaves | TPC, ORAC | [ | |
| Methanol | Rosmarinic and caffeic acids, luteolin-7- | Not specified | TPC, FRAP | [ | |
| Aqueous | Eriodictyol, apigenin, caffeic acid, kaempferol | Not specified | TPC, DPPH | [ | |
| Ethyl acetate, ethanol | Ethyl acetate: taxifolin di- | Aerial parts | TPC, superoxide | [ |
A summary of the anti-inflammatory properties of flavonoids and phenolic acids of different oregano species.
| Oregano Species | Compounds | Effect | Reference |
|---|---|---|---|
| Kaempferol, chlorogenic acid, caffeic acid | Reduction of NO and ROS production and inhibition of the protein levels and gene expression of IL-6, TNF-α, iNOS and COX-2 in LPS-stimulated RAW 264.7 murine macrophages | [ | |
| Neochlorogenic acid, Luteolin-7- | Reduction of the levels of NO and ROS produced in murine macrophage cells | [ | |
| Quercetin- | Inhibition of the NO and ROS production in LPS-stimulated murine macrophage cells | [ | |
| Quercetin- | Decrease of the levels of NO and ROS produced in murine macrophage cells | [ | |
| Caffeic acid | Diminution of IL-8 secretion in HT-29 and PC3 cells | [ |
A summary of the anti-cancer properties of flavonoids and phenolic acids of different oregano species.
| Oregano Species | Anti-Cancer Activity | Effect | Reference |
|---|---|---|---|
| Cytotoxic | Activity against human bronchial epidermoid carcinoma (NSCLC-N6) and murine leukemia (P388) cells line. | [ | |
| Cytotoxic | Activity against human breast cancer cells (MCF-7) | [ | |
| Antiproliferative | Inhibit human breast cancer (MCF-7) cell proliferation. | [ | |
| Antiproliferative | Reduction in the proliferation of human breast cancer cells (MFC-7). | [ | |
| Antiproliferative | Reduction in the proliferation of human breast cancer (MFC-7), colorectal cancer (LoVo), cervical epithelial carcinoma (HeLa) cells and selective antiproliferative activity on hepatic cancer cells (HepG2). | [ | |
| Cytotoxic | Showed signs of cells death on cervical epithelial carcinoma (HeLa) cell line and cytotoxicity for breast cancer and colon adenocarcinoma (Caco-2) cells. | [ | |
| Cytotoxic | Activity against breast (MCF-7), lung (H-460) and central nervous system (SF-268) human cancer cell lines. | [ | |
| Antiproliferative | Inhibit
| [ | |
| Cytotoxic | Activity against fibrosarcoma (HT-1080) cell line. | [ | |
| Antiproliferative | Inhibit cervical epithelial carcinoma (HeLa) cell proliferation. | [ | |
| Cytotoxic | Activity against human colon cancer cells (HT-29). | [ |